Suppl. Fig. 1: Butein affects the ALDHbright cell number in MPM cell cultures. A.Butein does not inhibit the ALDH enzyme. Graph showing the number of ALDH bright cells in time (0-90h) after treatment with butein or DEAB (diethylaminobenzaldehyde, 5M), a specific ALDH inhibitor. Average and s.e.m of triplicate experiments. B. Histograms show the percentage of ALDH bright cells in the indicated MPM cell cultures treated for 24hrs with vehicle (V: DMSO 0.05%) and Butein (B: 18M), alone or in combination with pemetrexed + cisplatin (P+C: 10M + 5M, respectively) and stained for ALDH activity at 96hrs. The percentage of ALDH bright cells was determined over the same cells treated with a specific ALDH inhibitor (DEAB) immediately after adding the ALDH substrate (BAA). Average + s.e.m of triplicate experiments. Suppl. Fig. 2: Butein modulates the DDIT3 mRNA levels. Quantitative PCR. DDIT3 mRNA levels of three representative MPM cell lines treated with butein (18M) for the indicated times. Histogram bars represent the mean ± s.e.m of ≥ three experiments. Statistics: p<0.05. Statistics: * p<0.05; ns=not significant: (p>0.05). Student's t-test (comparing each sample to its control at 0hrs) Suppl. Fig. 3: Butein affects the levels of STAT3 target genes in ALDHbright and ALDHlow cells. mRNA levels of multiple STAT3 target genes in MSTO-211H ALDH bright vs ALDH low cells, upon treatment with vehicle (upper) or butein (18M) (lower) for 24hrs. Histogram bars show the average + s.e.m of duplicate experiments.
